Table 2 Associations between LCN2 expression and metastatic spread among 215 endometrial cancers
From: Lipocalin 2 expression is associated with aggressive features of endometrial cancer
Variable | Site of tumor recurrence | LCN2 SI 0N (%) | LCN2 SI 1-9N (%) | P-valuea |
|---|---|---|---|---|
Recurrent diseaseb | No tumor recurrence | 96 (55%) | 78 (45%) | 0.029 |
Vaginal cuff | 11 (79%) | 3 (21%) | ||
Pelvic lymph nodes | 2 (67%) | 1 (33%) | ||
Distant metastasis (not liver) | 9 (50%) | 9 (50%) | ||
Liver | 0 (0%) | 6 (100%) |